Many liver cancer cases are diagnosed at advanced and inoperable stages, at this point, the disease is highly lethal and most patients do not survive more than a year. Currently, the front-line treatment for inoperable liver cancer is antibody-based immunotherapy, but only 30% of patients respond to this therapy. Our lab has developed a lipid […]
Read More